Cable Hill Partners’s Genomic Health, Inc. GHDX Stock Holding History

Cable Hill Partners’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-77	Closed	-$5K	–	817
2019 Q1	$5K	Hold	77	–	–	﹤0.01%	638
2018 Q4	$5K	Hold	77	–	–	﹤0.01%	586
2018 Q3	$5K	Sell	77 -14	-15%	-$819	﹤0.01%	597
2018 Q2	$5K	Hold	91	–	–	﹤0.01%	691
2018 Q1	$3K	Sell	91 -142	-61%	-$4.71K	﹤0.01%	800
2017 Q4	$8K	Hold	233	–	–	﹤0.01%	635
2017 Q3	$7K	Sell	233 -3	-1%	-$95	﹤0.01%	695
2017 Q2	$8K	Buy	+236	New	+$7.48K	﹤0.01%	469

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cable Hill Partners's GHDX Position: Q2 2019 in Review

Cable Hill Partners sold out of Genomic Health, Inc. (GHDX) in Q2 2019, closing a stake of 77 shares — an estimated $5K sold.

Cable Hill Partners first reported a position in GHDX in Q2 2017 and held it in 8 quarters. The position peaked at $8K in Q4 2017. 215 funds tracked by Wall St. Rank hold GHDX as of Q2 2019.

Cable Hill Partners reported no remaining Genomic Health, Inc. position as of Q2 2019 after selling out during the quarter.
Cable Hill Partners sold 77 Genomic Health, Inc. shares in Q2 2019, an estimated $5K.
Cable Hill Partners first reported a position in Genomic Health, Inc. in Q2 2017 and held it in 8 quarters.
Cable Hill Partners's Genomic Health, Inc. position peaked at $8K in Q4 2017.
215 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q2 2019.

Based on Cable Hill Partners's 13F filing for Q2 2019, filed 6 Aug 2019.